eM Client email app launches groundbreaking version 10 with AI support
(Prague, Czech 17.7.2024) - The Czech company eM Client releases a new version of the eponymous application for Windows, Mac, Android and iOS. eM Client is a popular tool for managing (not only) emails, which has become the main challenger to Microsoft Outlook for both end users and businesses. Version 10 brings the largest number of new features and improvements in the history of the product.
eM Client now includes full AI integration (via ChatGPT), which makes it easier for users to write messages and allows for quick text editing such as shortening, lengthening, changing tone, proofreading, summarizing and much more. Working with email has never been so efficient.
Another new feature is the automatic sorting of inbox messages into categories. This feature (especially with its wide customization options) allows users to focus on those messages that are really important.
A huge innovation is the redesigned chat interface, which now supports modern group communication platforms such as MS Teams, Slack and IceWarp TeamChat (with more to follow). These services are fully integrated in the application's interface.
Another useful new feature - "Quick Actions" - allows creation of macros to automate common tasks. The "Data Files" function allows you to work with external data files including PST files. The search system has been redesigned and now supports complex queries including NOT and OR operators. Other changes include a new clear design of conversations, synchronization of conversations for Exchange, Mentions, optional folder colors, custom colors for unread messages or a quick preview of PDF attachments.
Version 10 contains hundreds of additional improvements and optimizations, often implemented based on user feedback. Version 10 features are available now on Windows and macOS, and will gradually make their way to the mobile version.
With version 10, the licensing system is also changing. It consists of a Personal license, which can be used on up to three devices for individual use, and a Business license, designed for companies. Both licenses can now also be used in annual subscription mode. Free license terms remain unchanged.
Contacts
Schwartz Public Relations
Emma Ethell
ee@schwartzpr.de
Tel.: +49 (0) 89 211 871 39
www.schwartzpr.de
Images
About eM Client
eM Client (www.emclient.com) was founded in 2006 with a clear goal: to develop the best email application. eM Client combines a wide range of functionality with a modern and intuitive interface. Its qualities, including professional support, are appreciated by more than 2,500,000 users and 100,000 companies worldwide.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
Dr. Stefanie Kesting appointed as CEO of Thyssengas7.1.2026 14:06:26 CET | Press release
Dortmund, 06.01.2026 As of January 1, 2026, Dr. Stefanie Kesting has been appointed as the new Chief Executive Officer (CEO) of Thyssengas GmbH. She succeeds Dr. Thomas Gößmann, who will retire at the end of February 2026 after nearly nine years at the helm of the company. The leadership transition was announced in autumn 2025.
30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength7.1.2026 08:59:31 CET | Press release
To mark its 30th anniversary, the European Spas Association (ESPA) has released a special commemorative publication highlighting the strategic role of Europe’s medical spas and climate-health resorts in an era defined by prevention, longevity and sustainable wellbeing.
Forum for a self-reliant and self-determined Europe - the "Sovereign Europe Forum"23.12.2025 08:40:47 CET | Press release
Entrepreneurs, top managers and leaders from United Europe e.V. and European Forum Alpbach (EFA) are founding the Sovereign Europe Forum i.G.
Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release
youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom